Literature DB >> 11103893

Concurrent variable-interval drug self-administration and the generalized matching law: a drug-class comparison.

K G Anderson1, W L Woolverton.   

Abstract

It has previously been shown that self-administration of cocaine under concurrent variable-interval schedules is well described by the generalized matching law. That is, choice between two cocaine-maintained options was apportioned in accordance with relative frequency of reinforcement. However, the generality of this conclusion to drugs of other pharmacological classes has not been determined. In the present study, four male rhesus monkeys (Macaca mulatta) lever pressed under various pairs of concurrent variable-interval schedules with drug injection as the maintaining event. An opioid (alfentanil, 0.001 or 0.004 mg/kg/injection), a barbiturate (methohexital, 0.25 or 0.5 mg/kg/injection), and a psychomotor stimulant (cocaine, 0.05 mg/kg/injection) were selected as representatives of major classes of abused drugs and because of their relatively short duration of action. As has been found for cocaine, choice was well accounted for by the generalized matching law. There were no systematic differences in matching-law parameters across drugs and/or doses. As in earlier studies with drug and nondrug reinforcers, undermatching was a consistent finding. Therefore, the conclusion that relative reinforcement frequency is a crucial determinant of choice, as proposed by the generalized matching law, can be extended to behavior maintained by drugs from a variety of pharmacological classes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103893     DOI: 10.1097/00008877-200008000-00007

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

1.  Concurrent-chains schedules as a method to study choice between alcohol-associated conditioned reinforcers.

Authors:  Corina Jimenez-Gomez; Timothy A Shahan
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

2.  Effects of delay to reinforcement on the choice between cocaine and food in rhesus monkeys.

Authors:  William L Woolverton; Karen G Anderson
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

3.  The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.

Authors:  Natalie A Bratcher; Valeri Farmer-Dougan; James D Dougan; Byron A Heidenreich; Paul A Garris
Journal:  J Exp Anal Behav       Date:  2005-11       Impact factor: 2.468

4.  Quantification of drug choice with the generalized matching law in rhesus monkeys.

Authors:  Mikhail N Koffarnus; James H Woods
Journal:  J Exp Anal Behav       Date:  2008-03       Impact factor: 2.468

5.  A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: effects of candidate 'agonist-based' medications on sensitivity to reinforcement.

Authors:  Blake A Hutsell; S Stevens Negus; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2014-11-20       Impact factor: 4.492

6.  Choice in quail neonates: the origins of generalized matching.

Authors:  Susan M Schneider; Robert Lickliter
Journal:  J Exp Anal Behav       Date:  2010-11       Impact factor: 2.468

7.  Dose and schedule determinants of cocaine choice under concurrent variable-interval schedules in rhesus monkeys.

Authors:  Karen G Anderson; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2004-07-23       Impact factor: 4.530

8.  Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse.

Authors:  David H Root; Anthony T Fabbricatore; David J Barker; Sisi Ma; Anthony P Pawlak; Mark O West
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

9.  Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Adv Pharmacol Sci       Date:  2012-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.